Stock listing
COV Stock Price, News, Filings & Events — Cleo Diagnostics Ltd
Selected listing: COV · ASX · AUD · AU
This page tracks Cleo Diagnostics Ltd's COV:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COV:ASX. COV:ASX is the stock-level entry point for investors researching Cleo Diagnostics Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cleo Diagnostics Ltd, trading under the ticker COV, is a public company based in Australia with a market capitalization of approximately AUD 33.4 million. The company focuses on innovative diagnostic solutions in the healthcare sector. Cleo Diagnostics aims to enhance patient care through advanced technology and research.

- Ticker
- COV:ASX
- Asset type
- Stock
- Market cap
- $32.2M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- ASX
- Currency
- AUD
Cleo Diagnostics Ltd COV:ASX stock context
This page tracks Cleo Diagnostics Ltd's COV:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COV:ASX. COV:ASX is the stock-level entry point for investors researching Cleo Diagnostics Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cleo Diagnostics Ltd, trading under the ticker COV, is a public company based in Australia with a market capitalization of approximately AUD 33.4 million. The company focuses on innovative diagnostic solutions in the healthcare sector. Cleo Diagnostics aims to enhance patient care through advanced technology and research.
Latest news from Cleo Diagnostics Ltd
Research Cleo Diagnostics Ltd
Cleo Diagnostics Ltd investor report
Review AI stock analysis and investor report context for COV:ASX.
Cleo Diagnostics Ltd company profile
View the public company page for Cleo Diagnostics Ltd on 6ix.
Cleo Diagnostics Ltd news
Read company news and market updates connected to Cleo Diagnostics Ltd.
Cleo Diagnostics Ltd investor events
Find investor webinars, events, and replay context for Cleo Diagnostics Ltd.